Moderna, Inc. (MRNA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
140.92+7.04 (+5.26%)
At close: 4:00PM EDT
| Previous close | 133.88 |
| Open | 133.51 |
| Bid | 141.37 x 800 |
| Ask | 142.00 x 1000 |
| Day's range | 133.34 - 143.99 |
| 52-week range | 31.71 - 189.26 |
| Volume | 9,918,176 |
| Avg. volume | 11,174,095 |
| Market cap | 56.442B |
| Beta (5Y monthly) | 1.38 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.96 |
| Earnings date | 05 May 2021 - 10 May 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 174.25 |
- Motley Fool
3 Stocks That Could Suffer if Biden Gives In to This Pressure
A proposal currently before the World Trade Organization would waive patent rights on COVID-19 vaccines and treatments in an effort to help low-income nations. Several top Democrats appear to support the move, although the Biden administration has yet to state a position publicly. Despite the push, the president may be hesitant to override patents for pharmaceuticals.
- Yahoo Finance Video
"A big hit to the vaccine campaign": Doctor on Johnson & Johnson's vaccine delivery plunge
Suzanne Judd, Epidemiologist at the University of Alabama at Birmingham School of Public Health, joined Yahoo Finance to discuss the latest on covid-19.
- Zacks
Bristol Myers' (BMY) Opdivo Combo Positive in ESCC Study
Bristol Myers (BMY) announces encouraging data from the late-stage study evaluating Opdivo plus chemotherapy and Opdivo plus Yervoy in ESCC study.
© 2021 Verizon Media. All rights reserved.
